MOUNTAINSIDE, NJ, March 16, 2016; PRNewswire — Androvia LifeSciences, a biotechnology company engineering solutions for the advancement of male fertility, today announced that data related to the company’s proprietary technology, the Cap-Score™ Sperm Function Test, will be presented in an oral session at the 41st Annual Conference of the American Society of Andrology (ASA), to be held April 2 – 5, 2016 in New Orleans, Louisiana. Three additional studies related to the Cap-Score Sperm Function Test will be presented in poster sessions.